News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Lonza CEO Quits As Profit Tumbles, Shares Drop
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Lonza (LONN.VX: Quote, Profile, Research) Chief Executive Markus Gemuend quit on Tuesday as the specialty chemicals maker posted a dire 59 percent drop in 2003 profit, hit by oversupply in the biotechnology market.
Twitter
LinkedIn
Facebook
Email
Print
People
Lonza
MORE ON THIS TOPIC
Layoff Tracker
Eikon Cuts Workforce by 15%, Citing ‘External Forces’
May 22, 2025
·
210 min read
·
BioSpace Editorial Staff
Mergers & acquisitions
Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target
May 22, 2025
·
4 min read
·
Annalee Armstrong
BROUGHT TO YOU BY PLIANCY
Webinar: Are We There Yet? Surviving and Thriving in the Never-ending Biotech Downturn
May 21, 2025
·
1 min read
·
BioSpace Insights
Collaboration
Genentech Bets Again on Orionis With Potential $2B+ in Crowded Molecular Glue Space
May 21, 2025
·
2 min read
·
Tristan Manalac
